Yvonne Lopez
Family · Lubbock, TXNPI 1598244865
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,128 of the $5,251 with a category attached, or 78.6%. 25 manufacturers reported payments, led by Vantive US Healthcare LLC at 27.1% of the total. 2025 is the largest year on record at $2,372, 3.6 times the $658 reported in 2021. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $28.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vantive US Healthcare LLC$1K
- Otsuka America Pharmaceutical, Inc.$762
- Bayer$465
- OPKO Pharmaceuticals, LLC$407
- Amgen$339
- Akebia Therapeutics Inc$313
- plus $2K from 19 others
What the payments were for
- Travel & lodging$1,03520%
- Food & beverage$4,12879%
- Education$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vantive US Healthcare LLC | 12 | $1,421 |
| Otsuka America Pharmaceutical, Inc. | 36 | $762 |
| Bayer | 26 | $465 |
| OPKO Pharmaceuticals, LLC | 19 | $407 |
| Amgen(2 entities) | 13 | $339 |
| Akebia Therapeutics Inc | 14 | $313 |
| AstraZeneca(2 entities) | 8 | $266 |
| Mallinckrodt Hospital Products Inc. | 8 | $213 |
| Novartis | 1 | $134 |
| Travere Therapeutics, Inc. | 6 | $111 |
| Medtronic | 1 | $110 |
| ANI Pharmaceuticals, Inc. | 4 | $97 |
| Boehringer Ingelheim | 6 | $97 |
| Fresenius USA Marketing, Inc. | 6 | $96 |
| Novo Nordisk | 4 | $77 |
| Daiichi Sankyo Inc. | 4 | $76 |
| Vifor Pharma, Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $42 |
| Amicus Therapeutics, Inc. | 2 | $36 |
| Atricure, Inc. | 1 | $34 |
| Ardelyx, Inc. | 2 | $32 |
| Calliditas Therapeutics US Inc. | 1 | $26 |
| Sanofi | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Renal - Chronic$1,156
- Fabhalta$134
- JYNARQUE$123
- ULTOMIRIS$123
- SYMPLICITY G3$110
How this compares
$5,251 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Midodrine Hcl | 14 | $838 |
| Losartan Potassium | 17 | $101 |
| Doxycycline Hyclate | 13 | $88 |
Paid to pharmacies, not to this prescriber.
Other family in Lubbock
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.